Australia TGA ARTG recordNeoGen Collagen Flex - Collagen dental regeneration membrane
Australia TGA ARTG Registered Device · Neoss Australia Pty Ltd · Collagen Matrix Inc · Class III · Started August 12, 2021
Good Name: Neoss Australia Pty Ltd - NeoGen Collagen Flex - Collagen dental regeneration membrane
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- August 12, 2021
- Effective Date
- August 12, 2021
- Country
- United States of America
- Address
- 15 Thornton Road, Oakland, NJ, 07436
NeoGen Collagen Flex is a bioresorbable, implantable collagen material that is intended for use in oral surgical procedures as a resorbable membrane material for use in • simultaneous use of guided bone regeneration (GBR)-membrane and implants; • augmentation around implants placed in immediate extraction sockets; • augmentation around implants placed in delayed extraction sockets; • localized ridge augmentation for later implantation; • alveolar ridge reconstruction for prosthetic treatment; • filling of bone defects after root resection, cystectomy or removal of retained teeth; • guided bone regeneration in dehiscence defects; and • guided tissue regeneration procedures in periodontal defects.
Access comprehensive regulatory information for NeoGen Collagen Flex - Collagen dental regeneration membrane in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Neoss Australia Pty Ltd, manufactured by Collagen Matrix Inc in United States of America. The device registration started on August 12, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.